Health Care • Biotechnology: Pharmaceutical Preparations
$14.07 ▲ +0.57
(+4.22%)
MKT CAP: $522.6M • VOL: 378.0K
52W L $9 52W H $27
CASH DIVIDEND YIELD
0.00%
ANNUAL RATE: $0.00 / SH
TOTAL SHAREHOLDER YIELD
1.85%
BUYBACK YIELD: 1.85%
FCF PAYOUT COVERAGE RATIO
0.0%
GAAP EPS PAYOUT: 0.0%
DIVIDEND SAFETY SCORE NO DIVIDEND
50/100
GROWTH STREAK: 0 CONSECUTIVE YRS
CBIO // EX-DIVIDEND & CAPITAL DISTRIBUTION SCHEDULE (DIV <GO>)
SPOT: $14.07
Crescent Biopharma Inc. (CBIO) DOES NOT CURRENTLY DISTRIBUTE A REGULAR CASH DIVIDEND. CAPITAL ALLOCATION PRIORITIZES INTERNAL R&D (-35.0% ROIC) AND OPPORTUNISTIC SHARE REPURCHASES (1.85% BUYBACK YIELD).